1081 BIIB059, a Monoclonal Antibody Targeting BDCA2, Decreases Type I Interferon-Related Genes Transcriptional Activity in Subjects With Systemic Lupus Erythematosus (SLE) and Active Cutaneous LE (CLE)

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.1094
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

FRI0315 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Biib059, a Monoclonal Antibody Targeting Bdca2 Following Intravenous (IV) and Subcutaneous (SC) Single or Multiple Doses Administration in Healthy Volounteers (HV) and Subjects With Active Systemic Lupus Erythematosus (SLE)

2018English

Type I Interferon and Systemic Lupus Erythematosus

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2011English

Systemic Lupus Erythematosus (SLE)

English

Systemic Lupus Erythematosus (SLE)

English

Differential Methylation of Interferon-Related Genes Is Associated With Autoantibody Production in Systemic Lupus Erythematosus

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Malignancy in Systemic Lupus Erythematosus (SLE) Patients

Asian Pacific Journal of Cancer Prevention
2018English

Genome-Wide DNA Methylation Analysis of Chinese Patients With Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway

PLoS ONE
Multidisciplinary
2017English

Type I Interferon Predicts an Alternate Immune System Phenotype in Systemic Lupus Erythematosus

ACR Open Rheumatology
2019English

SAT0235 BIIB059, a Monoclonal Antibody Targeting BCDA2 Shows Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteer Subjects

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy